Goff Brian
SEC CIK 1546216 · EDGAR
BoughtSold
Most active insiders at NTLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| 2 | Cohen Fred E | Dir | $1.40M | — |
| 3 | Dulac Edward J III | EVP, CFO | — | $234.2K |
| 4 | BASTA JAMES | EVP, GC | — | $112.4K |
| 5 | Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| 6 | Dube Michael P | VP, CAO | — | $104.4K |
| 7 | Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| 8 | Schultes Birgit C | EVP, CSO | — | $78.9K |
| 9 | Bhanji Muna | Dir | — | — |
| 10 | Keresty Georgia | Dir | — | — |
| 13 | Goff Brian | Dir | — | — |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 19:02 | 2026-06-09 | NTLA | Intellia Therapeutics, Inc. | Goff Brian | Dir | A - Grant | $0.00 | +9,200 | 32.6K | +39% | $0 |
| DMT | 2026-04-06 16:04 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +39.0K | 191.1K | +26% | $0 |
| DMT | 2026-04-06 16:04 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $34.71 | -19.1K | 184.5K | -9% | -$661.9K |
| DM | 2026-03-03 | 2026-03-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $28.96 | -18.1K | 157.5K | -10% | -$522.9K |
| DM | 2026-03-03 | 2026-03-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +39.5K | 170.5K | +30% | $0 |
| DM | 2026-01-02 | 2025-12-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +38.3K | 149.1K | +35% | $0 |
| DM | 2026-01-02 | 2025-12-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $27.09 | -18.7K | 143.1K | -12% | -$506.7K |
| D | 2025-08-12 | 2025-08-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +22.7K | 134.6K | +20% | $0 |
| D | 2025-08-12 | 2025-08-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $36.67 | -11.1K | 123.5K | -8% | -$406.5K |
| DM | 2025-06-26 | 2025-06-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +38.3K | 117.9K | +48% | $0 |
| DM | 2025-06-26 | 2025-06-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $33.54 | -18.7K | 111.9K | -14% | -$627.2K |
| D | 2025-06-13 | 2025-06-11 | NTLA | Intellia Therapeutics, Inc. | Goff Brian | Dir | A - Grant | $0.00 | +8,000 | 23.4K | +52% | $0 |
| DM | 2025-03-04 | 2025-03-01 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +26.5K | 87.3K | +44% | $0 |
| DM | 2025-03-04 | 2025-03-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $35.54 | -12.9K | 92.3K | -12% | -$460.1K |
| D | 2024-08-12 | 2024-08-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +22.7K | 89.9K | +34% | $0 |
| D | 2024-08-12 | 2024-08-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $42.75 | -11.1K | 78.8K | -12% | -$474.1K |
| D | 2024-06-17 | 2024-06-13 | NTLA | Intellia Therapeutics, Inc. | Goff Brian | Dir | A - Grant | $0.00 | +15.4K | 15.4K | New | $0 |
| D | 2024-06-07 | 2024-06-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $48.84 | -12.1K | 67.2K | -15% | -$591.7K |
| D | 2024-06-07 | 2024-06-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +25.5K | 79.3K | +47% | $0 |
| D | 2024-03-05 | 2024-03-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $32.57 | -4,156 | 53.8K | -7% | -$135.4K |
| D | 2024-03-05 | 2024-03-01 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +8,500 | 57.9K | +17% | $0 |
| D | 2024-01-24 | 2024-01-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +17.0K | 57.1K | +42% | $0 |
| D | 2024-01-24 | 2024-01-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $21.64 | -7,635 | 49.4K | -13% | -$165.2K |
| D | 2024-01-09 | 2024-01-09 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $22.99 | -12.1K | 40.1K | -23% | -$277.4K |
| D | 2024-01-09 | 2024-01-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +25.5K | 52.1K | +96% | $0 |
| D | 2023-08-10 | 2023-08-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $25.48 | -10.2K | 26.6K | -28% | -$259.3K |
| D | 2023-08-10 | 2023-08-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +22.7K | 36.8K | +161% | $0 |
| D | 2023-06-30 | 2023-06-28 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | M - OptEx | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2023-06-30 | 2023-06-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | CEO, Dir | S - Sale+OE | $28.36 | -11.4K | 14.1K | -45% | -$324.7K |
Purchase Sale Sale after option exercise All abbreviations